Engineered clinical-grade mesenchymal stromal cells combating SARS-CoV-2 omicron variants by secreting effective neutralizing antibodies

BACKGROUND: The emergence of SARS-CoV-2 becomes life-threatening for the older and immunocompromised individuals, whereas limited treatment is available on these populations. Mesenchymal stromal cells (MSCs) have been reported to be useful in SARS-CoV-2 treatment and reduce SARS-CoV-2-related sequel...

Descripción completa

Detalles Bibliográficos
Autores principales: Wang, Yanning, Gao, Tianyun, Li, WanTing, Tai, Chenxu, Xie, Yuanyuan, Chen, Dong, Liu, Shuo, Huang, Feifei, Wang, Wenqing, Chen, Yuxin, Wang, Bin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470189/
https://www.ncbi.nlm.nih.gov/pubmed/37653459
http://dx.doi.org/10.1186/s13578-023-01099-z

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10470189/
https://www.ncbi.nlm.nih.gov/pubmed/37653459
http://dx.doi.org/10.1186/s13578-023-01099-z

Ejemplares similares